The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of adjuvant anti-PD-1 antibodies and interferon in patients with nail apparatus melanoma: A retrospective, multicenter study (ADJ-NAIL study).
 
Takaya Komori
Speakers' Bureau - MSD; Novartis Pharmaceuticals UK Ltd.
 
Eiji Nakano
No Relationships to Disclose
 
Yukiko Kiniwa
Honoraria - AstraZeneca; Bristol-Myers Squibb Japan; Mitsubishi Tanabe Pharma; Novartis; Novartis; Ono Pharmaceutical; Otsuka; Sanofi
 
Shoichiro Mori
No Relationships to Disclose
 
Sotaro Yamamoto
No Relationships to Disclose
 
Hiroshi Kato
No Relationships to Disclose
 
Shusuke Yoshikawa
No Relationships to Disclose
 
Koji Yoshino
No Relationships to Disclose
 
Megumi Aoki
No Relationships to Disclose
 
Tatsuya Takenouchi
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical
 
Takuya Maeda
Research Funding - Maruho
Travel, Accommodations, Expenses - Maruho; Novartis; Sun Pharma
 
Keijun Yoshino
No Relationships to Disclose
 
Shuichi Ohe
No Relationships to Disclose
 
Kenta Nakama
No Relationships to Disclose
 
Hideyuki Ishikawa
No Relationships to Disclose
 
Yoshiyuki Nakamura
No Relationships to Disclose
 
Toshihiro Takai
Speakers' Bureau - Ono Pharmaceutical
 
Takamichi Ito
No Relationships to Disclose
 
Yasuhiro Nakamura
Honoraria - Bristol-Myers Squibb Japan; Kyowa Kirin International; LEO Pharma; Maruho; Mitsubishi Tanabe Pharma; MSD Oncology; Novartis Pharmaceuticals UK Ltd.; Ono Pharmaceutical; Pierre Fabre; Sun Pharma
Consulting or Advisory Role - MSD Oncology; Novartis Pharmaceuticals UK Ltd.
Research Funding - MSD Oncology (Inst); Parexel/CALYX (Inst)
 
Shigeto Matsushita
Speakers' Bureau - Novartis Pharmaceuticals UK Ltd.; ONO/Bristol-Myers Squibb